Long-Term Results of Reconstruction with Pelvic Allografts after Wide Resection of Pelvic Sarcomas

Table 3

An overview of the patient data (Resec.: resection, Che: chemoteraphy, f/u: follow-up).

Case

Gender/; age at diagnosis

Tumor type

Grade

Resec.; zone

THA

Operation time; (hours)

Transfusion; (mL)

Margins

Che

Complication

Tumor condition

Walking

MSTS score (%)

Latest f/u

Allograft survival (months)

Patient survival (months)

Reoperation

1

F/15

Osteosarcoma

IIB

I-II

+

5

7

Wide

+

Resorption; Dislocation

No evidence of disease

Without support

74

No evidence of disease

46

113

Revision with allogreft

2

M/52

Malignant; fibrous histiocytoma

III

II-III

+

5

6

Wide

−

Infection

Metastasis

1 crutch

54

Died at 13 months

3

13

Debridement Implant removal

3

F/13

Postradiation osteosarcoma

IIB

I-II

+

4

6

Marginal

+

—

Local recurrence

1 crutch

57

Died at 36 months

25

36

External hemipelvectomy

4

M/16

Ewing

IIB

I-II

+

5

7

Wide

+

Resorption

Metastasis

1 crutch

67

Distant metastasis

24

95

Debridement

5

M/26

Ewing

IIB

I-II-III

+

6

8

Wide

+

—

No evidence of disease

Without support

87

No evidence of disease

83

118

—

6

M/12

Ewing

IIB

II-III

+

6

7

Wide

+

Infection

No evidence of disease

1 crutch

72

Died at 71 months

62

71

External hemipelvectomy

7

M/25

Giant cell tumor

3

II-III

+

4

6

Wide

−

Infection

No evidence of disease

1 crutch

68

No evidence of disease

26

73

Debridement; Implant removal

8

M/24

Chondrosarcoma

IIB

II-III

+

5

8

Wide

−

Infection

No evidence of disease

Without support

62

No evidence of disease

13

86

2-stage revision with custom made pelvis prosthesis

9

M/15

Osteosarcoma

IIB

I-II

+

5

8

Wide

+

Resorption

No evidence of disease

Without support

80

No evidence of disease

110

110

—